Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
1
Respiratory-Medication AdherenceDigital Health Solutions Kiwi Kids Programme
23 November 2018
Maggie Scott, Head of Clinical Operations Adherium NZ Ltd, Auckland, New [email protected]
Respiratory Treatments
• Inhaled medications are the mainstay of treatment for chronic respiratory diseases
• Inhaled Corticosteroids (ICS) are the mainstay for chronic persistent asthma
• ICS are effective for the greater majority of patients with asthma
Private & Confidential © 2018 Adherium NZ Ltd
However… Poor Disease Control is Widespread
• 40% - 50% asthma patients exhibit poor control despite access to effective treatments
Private & Confidential © 2018 Adherium NZ Ltd
“The leading global issue in the management of asthma is adherence to inhaled corticosteroids”
- Professor Peter BarnesDM, DSc, FRCP, FCCP, FMedSci, FRSNZ Lung Day, May 2015
Private & Confidential © 2018 Adherium NZ Ltd
How Can We Measure Medication Adherence?
• Self Report?
• Electronic Monitoring Devices (EMDs)?
* New Zealand Health SurveyPrivate & Confidential © 2018 Adherium NZ Ltd
Measuring Medication Adherence: Self Report
Patel et al, MRINZ Wellington– Patient over-use under-
estimated and under-use over-estimated
– Conclusion: Self report is not reliable
Burgess et al, Mater, Brisbane– Patients, Care Givers, Health
Professionals each over estimated adherence
– No way of determining who was reliable and who wasn’t reliable
– Conclusion: Self report is not reliable
Private & Confidential © 2018 Adherium NZ Ltd
Measuring Medication Adherence: Electronic Monitoring Devices (EMD)
Adherium HailieTM
A range of electronic sensors that clip on to standard prescription inhalers
Private & Confidential © 2018 Adherium NZ Ltd
Measuring Medication Adherence: Electronic Monitoring Devices (EMD)
Conclusion: EMDs are accurate tools for objectively measuring patient medication adherence
Private & Confidential © 2018 Adherium NZ Ltd
Medication Adherence in Aotearoa Chan et al: Children & Teens 6 – 15, n = 110/220, Starship ED• Chan AH, Stewart AW, Harrison J, Camargo CA, Black PN, Mitchell EA: The effect of an
electronic monitoring device with audio-visual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: A randomised controlled trial. The Lancet Respiratory Medicine 2015, 3(3): 210-19.
• Acute asthma• Emergency Department Attendance• On twice daily inhaled corticosteroid treatment• Measurement period 6 months• Electronic monitoring (Adherium Hailie)• Median Control Group ICS Adherence = 30%• Median Intervention Group ICS Adherence = 84%
Private & Confidential © 2018 Adherium NZ Ltd
Low ICS Medication Adherence isAssociated with Poor Outcomes
* Klok et al, ERJ 2014: Data collected using Adherium HailiePrivate & Confidential © 2018 Adherium NZ Ltd
Can Electronic Monitoring Devices (EMDs) Also Improve Medication Adherence?
Private & Confidential © 2018 Adherium NZ Ltd
Mini Meta-Analysis Assessing Impact of EMD(Track & Remind) on Medication Adherence
Study Year Mean SD Total Mean SD Total Weight IV, Random, 95% CI
Chan 2015 79 20 106 27 20 102 26.2% 52.00 (46.56, 57.44)
Charles 2007 88 16 44 66 27 46 26.2% 22.00 (12.88, 31.12)
Foster 2014 60 38 62 29 33 60 26.2% 31.00 (18.38, 43.62)
Morton 2016 70 20 39 49 20 38 26.2% 21.00 (12.06, 29.94
Total (95% CI)
74.3 251 42.8 246 100.0% 31.73 (13.91, 49.55)
Heterogeneity: Tau2 = 308.15; Chi2=52.34, df = 3 (P < 0.00001);12 = 94%Test for overall effect: Z = 3.49 (P = 0.0005)
Respiratory Drug Delivery Europe 2017 - Sutherland et al
Improvement in medication adherence due to EMD = 74%Private & Confidential © 2018 Adherium NZ Ltd
“The Smartinhaler could serve to improve interactions between people with asthma and their clinicians”
- National Institute for Health and Care Excellence: Smartinhaler for asthma. Medtech Innovation Briefing 90.
UK National Institute for Health and Care Excellence (NICE)
Private & Confidential © 2018 Adherium NZ Ltd
Adherium’s Hailie® Solution
Hailie Sensor Hailie App Hailie Cloud
Patient & Care Giver Health Professional
Private & Confidential © 2018 Adherium NZ Ltd
How Hailie™ Works
Patient clips Hailie Sensor on their prescription inhaler and uses as per normal.
1 Patient & Care-Giver can view medication use on the HailieTM App. Sensor reminders can be setup via the App.
2 Health Professional reviews inhaler usage on the HailieTM
App or Portal to discuss the best strategy for controlling the asthma in partnership with the Patient and their Caregiver
3
Private & Confidential © 2018 Adherium NZ Ltd
Hailie™ Setup in 3 Simple Steps
Sensors are compatible with a range of inhaler medications.
1 Receive the HailieTM sensor
Patients downloadthe App and Self-Enrollin the Programme
2 Download the HailieTM App
Patients can set reminders and start tracking medication usage
Start tracking inhaler usage
The HailieTM Sensor is paired to the App usingstep-by-step instructions
3 Pair via Bluetooth®
wireless
Private & Confidential © 2018 Adherium NZ Ltd
Private & Confidential © Adherium (NZ) Limited, 2016
17
Objective Patient Medication Use from ADR Hailie8
Private & Confidential © Adherium (NZ) Limited, 2016
18
Objective Patient Medication Use from ADR HailieⓇ9
Why Hailie™ for Kiwi Kids?
Reduction in Hospital Admissions for Children using the HailieTM
solution with missed dose reminders, over 12 months
Reduction in rescue medication use in children using the HailieTM
solution with missed dose reminders
Morton et al. (2016) Chan et al. (2015) Chan et al. (2015)
Private & Confidential © 2018 Adherium NZ Ltd
Hospitalisations
81%
Reliever Medication Use
46%
Reduction in emergency oral steroid use in children
using the HailieTM solution with missed dose reminders
Emergency Medication Use
37%
AotearoaCan we Change a Nation?
Private & Confidential © 2018 Adherium NZ Ltd
- Founded 2001, Auckland, by asthmatic
- Global Leader in connected smart inhalers
- More than 130,000 devices sold
- Monitored adherence > 200 Million hourslargest database in world
- Listed on Australian Stock Exchange, 2015
12
Private & Confidential © 2018 Adherium NZ Ltd
Hailie Kiwi Kids Programme
Understanding Our AsthmaAdherium seeks for New Zealand to be the 1st country in the world to electronically map asthma medication usage and environmental data at a national level. Data generated will be anonymised and shared with Programme research teams to discover new insights into asthma prevalence, and potential new improvements in asthma management that can be provided to NZ children and shared with the international respiratory community.
Our App will capture Patient:• Medication dosage and time• Geographic location (anon)• Temperature to within 1ºC• Other environmental conditions
and Program Metrics:• # Centers• # Users enrolled• # Active users• # Sensors
Private & Confidential © 2018 Adherium NZ Ltd
Benefits
• To improve the lives of thousands of kiwi kids with asthma• A World 1st initiative• National Dataset & Insights• Adherium and its Sponsors are covering the costs• The potential to change practice following great results in New Zealand
Private & Confidential © 2018 Adherium NZ Ltd
Kiwi Kids Programme Site Participation
1 Introduction & Invitation to Participate
2 Agreement & Appointment of a Site Champion
Deployment with Patients, Re-supply, and Support
3 Initial Supply & Hands-on Training
4
Private & Confidential © 2018 Adherium NZ Ltd
How to Get Involved
• Talk to us
• Assign a Site Champion
• Do the on-line training, try it with a patient
* New Zealand Health SurveyPrivate & Confidential © 2018 Adherium NZ Ltd
Private & Confidential © 2018 Adherium NZ Ltd